UK Pharmaceutical Supplier to Singapore
Singapore's Health Sciences Authority (HSA) regulates medicine registration, import and clinical trial supply under the Health Products Act. For medicines not yet registered in Singapore required for specific patient cases, HSA operates a Named Patient Supply (NPS) route for case-by-case import. Euro Biom is an MHRA-licensed UK pharmaceutical supplier working with Singapore's tertiary hospitals, private specialty clinics and clinical research organisations sourcing UK-origin branded, specialty, clinical trial comparator and shortage medicines, including UK-licensed medicines supplied under Singapore's named-patient import route. We hold WDA wholesale dealer authorisation, source from a catalogue of 5,700+ UK-licensed products, and prepare every export to HSA standards. Euro Biom trades exclusively in UK-licensed medicines.
Why Singapore Hospital Buyers Struggle to Source UK Medicines
Singapore's HSA oversight is among the strictest in ASEAN, and Singapore hospitals operate at international standards. Most UK wholesalers cannot meet the documentation, traceability and response standards Singapore buyers actually require.
HSA Named Patient Supply Requirements Are Strict
For medicines not yet registered in Singapore, Singapore treating physicians apply under HSA Named Patient Supply. The application requires a UK supplier with verifiable MHRA credentials and documentation structured to HSA expectations. Most UK wholesalers cannot meet those standards.
Changi Customs Expects Perfect Documentation
Singapore Customs at Changi is efficient but unforgiving. Consignments with incomplete or inconsistent Certificate of Pharmaceutical Product, GMP or GDP records are held for clarification, and Singapore's hospital-grade cold chain does not have days to spare.
Clinical Trial Supply Requires Specific Expertise
Singapore is a leading ASEAN hub for clinical trials, and comparator medicine supply has specific GMP, traceability and documentation requirements. Most UK exporters are not set up for trial-ready, GMP-documented supply.
Private Specialty Clinics Expect International Standards
Singapore's private specialty clinics and international hospital group operators expect supply chain standards equivalent to European and American wholesalers. Ad-hoc UK suppliers cannot match that level.
Urgent Oncology Cases at NCCS and SGH
National Cancer Centre Singapore, Singapore General Hospital and private oncology centres need UK-origin targeted therapies and rare disease orphan drugs on clinical timelines. Most UK exporters cannot respond fast enough to matter.
Single Accountability for Complex Cases
Singapore hospital pharmacy teams need one UK partner who owns the shipment from Heathrow to Changi, prepares every HSA document, and takes the call when anything needs clarification.
An MHRA-Licensed UK Wholesaler Built for Singapore Hospital Supply
Importing a specialty, named patient or clinical trial medicine into Singapore should be traceable, HSA-compliant and fast. Whether you are a consultant at NUH sourcing an NPS medicine, a pharmacy director at SGH managing a targeted therapy case, or a CRO running a clinical trial that needs UK-origin comparator medicine, we manage the UK side.
We hold MHRA Wholesale Dealer Authorisation WDA(H) 59239, source from a catalogue of 5,700+ UK-licensed medicines across 21 therapeutic areas, and prepare every shipment with HSA-aligned documentation. Every Certificate of Pharmaceutical Product, batch documentation and GDP record is structured to the requirements Changi customs checks, with a Certificate of Analysis included where the manufacturer makes one available.
Based at Heathrow, we dispatch via direct Changi air freight with validated cold chain containers and continuous monitoring. For NPS, clinical trial and urgent shortage cases, we respond the same day and dispatch within 24 to 48 hours once HSA permission is confirmed.
Discuss Your RequirementsWhy Singapore Hospital Buyers Choose Euro Biom
Practical reasons tertiary hospitals, private specialty clinics and clinical research organisations across Singapore work with us for UK medicines.
Publicly Verifiable MHRA Licence
WDA(H) 59239 on the UK MHRA public register. Your HSA liaison and hospital procurement teams verify us in under a minute.
HSA-Aligned Export Documentation
Certificate of Pharmaceutical Product, Certificate of Free Sale, GMP certificates, GDP chain of custody, and a Certificate of Analysis where the manufacturer makes one available, all prepared to HSA standards.
Named Patient Supply Expertise
We understand what Singapore treating physicians need to support an HSA NPS application. Clean documentation, traceable provenance, immediate dispatch once permission is confirmed.
Clinical Trial Supply Capability
UK-origin comparator medicine supply with GMP-compliant documentation and chain of custody and HSA-compliant import handling for Singapore clinical trials.
Verified UK Sourcing Catalogue
We source from a catalogue of 5,700+ UK-licensed products. When we confirm availability for a Singapore case, we have confirmed the line with a licensed UK source and can give you a real lead time.
Direct Cold Chain to Changi
Validated temperature-controlled containers with continuous monitoring on direct Heathrow to Changi air freight. No hub layover for temperature-sensitive UK-licensed medicines.
Same-Day Response
When a Singapore hospital or CRO needs UK-sourced medicine urgently, we confirm availability the same day and dispatch within 24 to 48 hours.
One Accountable Contact
Single point of contact from enquiry through to arrival at your hospital pharmacy or trial site in Singapore. One thread, full visibility.
Pharmaceutical Supply Services for Singapore
Four service lines built around what Singapore tertiary hospitals, private specialty clinics and clinical research organisations actually face when sourcing UK medicines.
HSA Named Patient Supply
For Singapore treating physicians sourcing medicines not yet registered in Singapore under HSA NPS. We provide UK-side sourcing from verified GMP manufacturers, HSA-aligned documentation, and immediate dispatch once permission is confirmed.
- HSA NPS documentation support
- UK GMP manufacturer sourcing
- Oncology, rare disease and specialty products
- Same-day response for urgent cases
Clinical Trial Comparator Medicine Supply
For Singapore clinical research organisations and academic trial sites requiring UK-origin comparator medicine. GMP-compliant chain of custody, HSA-compliant import handling and direct Heathrow to Changi dispatch.
- GMP-compliant chain of custody
- HSA-compliant import handling
- Direct Heathrow to Changi dispatch
- Batch-level documentation
Oncology and Specialty Supply
For National Cancer Centre Singapore, SGH, NUH and private oncology centres sourcing UK-origin targeted therapies and specialty oncology medicines. Validated direct cold chain with HSA-aligned documentation.
- Targeted therapies and specialty medicines
- Validated direct cold chain to Changi
- HSA-aligned customs documentation
- Certificate of Analysis where the manufacturer makes one available
Shortage and Specialty Supply
When a Singapore tertiary hospital or private specialty clinic faces a shortage, we provide UK-sourced alternatives with same-day availability confirmation and direct dispatch within 24 to 48 hours.
- Same-day availability confirmation
- UK-sourced alternatives
- Direct Heathrow dispatch
- GDP-compliant documentation
Built for Singapore Hospital Buyers
Procurement teams and treating physicians at tertiary hospitals, private specialty clinics and clinical research organisations across Singapore have chosen Euro Biom.
Our Process for Singapore Pharmaceutical Supply
From first enquiry to arrival at your hospital pharmacy or trial site in Singapore, the process is fast, traceable and HSA-compliant.
Step 1: Enquiry and Availability Check
You send the medicine name, strength, quantity and clinical or trial context. We confirm availability from UK supply the same day and outline the HSA documentation bundle.
Step 2: HSA Documentation Bundle
We prepare the export documentation pack from the CPP, GMP evidence, batch documentation and Free Sale Certificate available for each line, with full GDP chain of custody, structured to HSA standards.
Step 3: Direct Dispatch to Changi
Once payment and import permission are confirmed, we dispatch on direct Heathrow to Changi air freight. Temperature-sensitive products travel in validated containers with continuous monitoring.
Step 4: Customs and Delivery
We remain available throughout Singapore Customs clearance to respond to HSA or customs queries. Onward delivery to your hospital pharmacy or trial site is coordinated with your Singapore logistics partner.
Singapore Pharmaceutical Market Insight
Singapore's sophisticated healthcare system and regional hub status drive distinct import requirements.
Singapore's pharmaceutical market, valued at approximately USD 2.1 billion in 2024, operates within one of the world's most advanced and highly regulated healthcare systems. The Health Sciences Authority (HSA) maintains regulatory standards comparable to the FDA, EMA, and MHRA, making Singapore a founding member of the International Coalition of Medicines Regulatory Authorities (ICMRA). For UK pharmaceutical suppliers, this means documentation and quality standards are already closely aligned, creating efficient import pathways.
Singapore functions as both a domestic healthcare market and a regional pharmaceutical hub for Southeast Asia. The country's major hospital groups, SingHealth (Singapore General Hospital, National Cancer Centre, National Heart Centre), National University Health System (NUH, Ng Teng Fong General), and National Healthcare Group (Tan Tock Seng, TTSH), source specialist medicines globally and maintain formularies that include UK-origin branded and specialty products. Private hospital groups including Mount Elizabeth, Gleneagles, and Raffles Hospital also source imported medicines for medical tourism patients from across Asia.
The HSA operates a streamlined regulatory framework under the Health Products Act. For registered medicines, the standard evaluation pathway takes 270 working days, while the verification route (for medicines already approved by reference agencies including the MHRA) takes 180 working days. For medicines not yet registered in Singapore, Singapore's Special Access Route (SAR) and the Group Patient Special Access Scheme allow physicians to import specific medicines for named patients, this is the primary channel Euro Biom uses to supply UK medicines to Singaporean institutions.
Singapore's disease profile reflects an ageing population and high chronic disease burden. Oncology represents the largest specialist import category, with Singapore's National Cancer Centre treating patients from across ASEAN. Rare diseases and orphan drugs are another significant import category, Singapore's National Rare Diseases Registry identifies over 2,000 patients requiring specialist medicines not commercially available locally. Cardiology, neurology, and immunology complete the major therapeutic import categories driving demand for UK-sourced pharmaceuticals.
Frequently Asked Questions About UK Medicine Supply to Singapore
Practical questions from Singapore hospital pharmacy teams, CRO trial managers and oncology consultants.
Need a UK Pharmaceutical Supplier for Singapore
Same-day response. MHRA-licensed. HSA-aligned documentation. Direct dispatch from Heathrow to Singapore Changi. Tell us the medicine, clinical or trial context and timeline.
MHRA WDA(H) 59239 · Company No. 15380737 · Registered England and Wales · work@eurobiom.co.uk
Get a tailored quote: Pharmaceutical Supply to Singapore
Tell us what you need and our Heathrow team responds the same working day. UK-licensed, MHRA WDA(H) 59239, verify on the MHRA register.